Compare SVRA & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | BJRI |
|---|---|---|
| Founded | 2007 | 1978 |
| Country | United States | United States |
| Employees | N/A | 22000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 884.0M |
| IPO Year | 2009 | 1996 |
| Metric | SVRA | BJRI |
|---|---|---|
| Price | $4.71 | $42.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $7.33 | ★ $42.88 |
| AVG Volume (30 Days) | ★ 1.2M | 300.2K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 208.57 |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.71 |
| Revenue Next Year | $430.87 | $3.89 |
| P/E Ratio | ★ N/A | $104.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $28.46 |
| 52 Week High | $7.01 | $47.02 |
| Indicator | SVRA | BJRI |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 62.94 |
| Support Level | $3.36 | $40.92 |
| Resistance Level | $6.15 | $43.36 |
| Average True Range (ATR) | 0.27 | 1.71 |
| MACD | -0.03 | 0.25 |
| Stochastic Oscillator | 1.34 | 78.52 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.